Rash, strontium ranelate and DRESS syndrome put into perspective. European Medicine Agency on the alert

Osteoporosis International

Volumn 19, Issue 12, 2008, Pages 1811-1812

  Pernicova, I ^a   Middleton, E T ^a   Aye, M ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; STRONTIUM RANELATE;

CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; EUROPE; FEMALE; FEVER; HUMAN; LETTER; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; SIDE EFFECT;

BONE DENSITY CONSERVATION AGENTS; DRUG HYPERSENSITIVITY; HUMANS; ORGANOMETALLIC COMPOUNDS; SYNDROME; THIOPHENES;

EID: 55049136706     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0734-8     Document Type: Letter

References (4)

1. European Public Assessment Reports (EPARs) for authorised medicinal products for human use. Protelos. Press Release (2007) Available at http://www.emea.europa.eu/humandocs/PDFs/EPAR/protelos/ PressRelease_Protelos_41745807en.pdf
2. European Public Assessment Reports (EPARs) for authorised medicinal products for human use. Protelos. Product information. Annex I - summary of product characteristics. Section 4.4, 4.8. (2008) Available at http://www.emea.europa.eu/humandocs/PDFs/EPAR/protelos/H-560-PI-en.pdf
3. European Public Assessment Reports (EPARs) for authorised medical products for human use. Osseor. Product information. Annex I - summary of product characteristics. Section 4.4, 4.8. (2008) Available at http://www.emea.europa.eu/humandocs/PDFs/EPAR/osseor/H-561-PI.en.pdf
4. JY Reginster E Seeman MC De Vernejoul 2005 Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 5 2816 2822